Liberum Capital Reaffirms Buy Rating for PureCircle Limited (PURE)

Liberum Capital restated their buy rating on shares of PureCircle Limited (LON:PURE) in a research report report published on Monday morning. They currently have a GBX 500 ($6.60) price target on the stock.

Separately, Kepler Capital Markets downgraded shares of PureCircle Limited to a reduce rating and reduced their price target for the company from GBX 410 ($5.41) to GBX 390 ($5.15) in a report on Tuesday, October 3rd.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/11/02/liberum-capital-reaffirms-buy-rating-for-purecircle-limited-pure.html.

In other PureCircle Limited news, insider Christopher Dale Pratt sold 44,630 shares of the stock in a transaction on Thursday, September 21st. The shares were sold at an average price of GBX 460 ($6.07), for a total value of £205,298 ($270,913.17).

PureCircle Limited Company Profile

PureCircle Limited is a producer of stevia ingredients for the global food and beverage industry. The Company focuses on encouraging healthier diets around the world through the supply of natural ingredients to the global food and beverage industry. The Company has over 40 stevia-related patents. The Company’s Zeta Family ingredients consists of the sugar, such as steviol glycosides, including Reb M and Reb D, and allow for the deepest calorie reductions by food and beverage companies.

Receive News & Ratings for PureCircle Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureCircle Limited and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply